In Brief: Glaxo Wellcome Retrovir
Executive Summary
Glaxo Wellcome Retrovir: Zidovudine, AZT capsules and syrup efficacy supplement approved Oct. 4 to include clinical trial data from ACTG 175, which showed AZT in combination with Roche's Hivid (zalcitabine, ddC) was superior in delaying disease progression compared to AZT alone...